Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00246480 · ClinicalTrials.gov registry record
RSV Disease in the Elderly
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 1,401
- Enrollment target
NCT00246480 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 1,401 participants.
The verdict
NCT00246480 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 1,401 participants
- Enrollment target
Study Summary
Respiratory syncytial virus (RSV) causes sickness and deaths in older people every winter. This study will investigate how aging affects the body's immune response (body's response to disease) to RSV. About 2000 people, age 21 and older, who reside in the upstate NY area, will be recruited. Two groups of subjects will be studied. The 1st group of volunteers will be recruited prior to the start of RSV season in year 1 of the study. These volunteers will include healthy people and people with various medical conditions. The 2nd group of volunteers will be patients admitted to Rochester General Hospital for acute respiratory illness. Procedures will include drawing blood from a vein in the arm (2 tablespoons), collecting nasal swabs, and collecting sputum. Volunteers may participate in study related procedures for up to 3 years.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,401 participants |
| Start Date | 2005-10-03 |
| Est. Completion | 2008-05-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00246480
The ClinicalTrials.gov registry entry for NCT00246480 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,401 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00246480 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00246480 about?
NCT00246480 is a clinical study titled "RSV Disease in the Elderly". Respiratory syncytial virus (RSV) causes sickness and deaths in older people every winter. This study will investigate how aging affects the body's immune response (body's response to disease) to RSV. About 2000 people, age 21 and older, who reside in the upstate NY area, will be recruited. Two grou...
What is the current status of trial NCT00246480?
This trial is currently completed. The enrollment target is 1,401 participants. The study started on 2005-10-03. Estimated completion is 2008-05-28.
Who is sponsoring clinical trial NCT00246480?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.